PET imaging of prostate cancer with 11C-acetate

Journal of Nuclear Medicine

Volumn 44, Issue 4, 2003, Pages 556-558

  Dimitrakopoulou Strauss, Antonia ^a   Strauss, Ludwig G ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID C 11; METHIONINE C 11; PROSTATE SPECIFIC ANTIGEN; ACETIC ACID DERIVATIVE; CARBON; CARBON 11 ACETATE; CARBON-11 ACETATE; DIAGNOSTIC AGENT;

ANTIGEN SPECIFICITY; BIOINFORMATICS; BLADDER; BONE METASTASIS; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER IMMUNOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CELL MEMBRANE; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INJECTION; KIDNEY; LYMPH NODE METASTASIS; METABOLISM; METASTASIS; NOTE; OXIDATION; PELVIS LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATECTOMY; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SERUM; URINARY EXCRETION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; MALE; METHODOLOGY; PROSTATE TUMOR; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

ACETATES; CARBON; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0038654367     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (19)

1. Von Eschenbach A, Ho R, Murphy GP, Cunningham M, Lins N American Cancer Society guideline for the early detection of prostate cancer, update 1997. CA Cancer J Clin 1997;47:261-264.
2. Catalona WJ, Smith DS. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol. 1994;152:1837-1842
3. Arcangeli CG, Ornstein DK, Keetch DW, Andriole GL. Prostate-specific antigen as a screening test for prostate cancer. Urol Clin North Am 1997;24: 299-314.
4. Effert PJ, Bares R, Handt S, Wolff JM, Bull U, Jakse G Metabolic imaging of untreated prostate cancer by positron emission tomography with 18-fluorine-labeled deoxyglucose. J Urol. 1996;155.994-998.
5. Hofer C, Laubenbacher C, Block T, Breul J, Hartung R, Schwaiger M. Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Eur Urol 1999;36:31-35.
6. 18F)fluorodeoxyglucose in untreated prostate cancer. Jpn J Clin Oncol. 1999;29:623-629.
7. Shreve PD, Grossman HB, Gross MD, Wahl RL. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-(F-18)fluoro-D-glucose. Radiology. 1996;199:751-756.
8. Morris MJ, Akhurst T, Osman I, et al. Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer Urology. 2002;59:913-918.
9. 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer. J Nucl Med. 2002,43:46-55.
10. Shreve P, Chiao PC, Humes HD, Schwaiger M, Gross MD. Carbon-11-acetate PET imaging in renal disease J Nucl Med 1995;36:1595-1601
11. 11C-acetate PET imaging of prostate cancer J Nucl Med. 2002;43:181-186
12. 11C) acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer. Eur J Nucl Med 2002,29:1492-1495.
13. Kotzerke J, Volkmer BJ, Neumaier B, Gschwend JE, Hautmann RE, Reske SN. Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer. Eur J Nucl Med 2002;29:1380-1384
14. 11C-Acetate PET imaging of prostate cancer. detection of recurrent disease at PSA relapse. J Nucl Med 2003;44:549-555.
15. Yoshimoto M, Waki A, Yonekura Y, et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol 2001;28 117-122
16. Liu RS. Clinical application of (C-11)acetate in oncology [abstract]. Clin Positron Imaging 2000;3:185
17. 11C-choline positron emission tomography. Eur Urol. 2002;42:18-23
18. 18F-labeled choline analogs as oncologic PET tracers. J Nucl Med 2001,42:1805-1814.
19. 18F- fluoroethylcholine for cancer imaging with PET synthesis, biochemistry, and prostate cancer imaging. J Nucl Med. 2002;43 187-199.